In vitro synergy of penicillin, ceftriaxone and levofloxacin against serotype 19A Streptococcus pneumoniae

被引:1
作者
Tsai, Hsih-Yeh [1 ]
Liao, Chun-Hsing [1 ]
Liu, Chia-Ying [1 ]
Huang, Yu-Tsung [1 ]
Hsueh, Po-Ren [2 ,3 ]
机构
[1] Far Eastern Mem Hosp, Dept Internal Med, New Taipei City, Taiwan
[2] Natl Taiwan Univ, Coll Med, Dept Internal Med, Natl Taiwan Univ Hosp, Taipei, Taiwan
[3] Natl Taiwan Univ, Coll Med, Dept Lab Med, Natl Taiwan Univ Hosp, Taipei 10764, Taiwan
关键词
D O I
10.1016/j.ijantimicag.2015.07.018
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
引用
收藏
页码:722 / 725
页数:5
相关论文
共 50 条
  • [31] Bacteremia caused by a highly-resistant Streptococcus pneumoniae serotype 19A circulating in a daycare center
    Shouval, Dror S.
    Porat, Nurith
    Dagan, Ron
    Keller, Nathan
    Bilavsky, Efraim
    Sivan, Yoram
    Amir, Jacob
    INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES, 2010, 14 : E253 - E255
  • [32] IN-VITRO ANTIMICROBIAL EFFECT AGAINST STREPTOCOCCUS-PNEUMONIAE OF ADDING RIFAMPIN TO PENICILLIN, CEFTRIAXONE, OR 1-OFLOXACIN
    GIRON, KP
    GROSS, ME
    MUSHER, DM
    WILLIAMS, TW
    THARAPPEL, RA
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1995, 39 (12) : 2798 - 2800
  • [33] CLINICAL FEATURES AND OUTCOME OF EMPYEMA THORACIS FROM STREPTOCOCCUS PNEUMONIAE SEROTYPE 19A IN THAI CHILDREN
    Suandork, Porntep
    RESPIROLOGY, 2014, 19 : 204 - 204
  • [34] Whole genome sequencing of macrolide resistant Streptococcus pneumoniae serotype 19A sequence type 416
    Spanelova, Petra
    Jakubu, Vladislav
    Malisova, Lucia
    Musilek, Martin
    Kozakova, Jana
    Papagiannitsis, Costas C.
    Bitar, Ibrahim
    Hrabak, Jaroslav
    Pantosti, Annalisa
    del Grosso, Maria
    Zemlickova, Helena
    BMC MICROBIOLOGY, 2020, 20 (01)
  • [35] Emergence of Streptococcus pneumoniae of serotype 19A in France: molecular capsular serotyping, antimicrobial susceptibilities, and epidemiology
    Dortet, Laurent
    Ploy, Marie-Cecile
    Poyart, Claire
    Raymond, Josette
    DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE, 2009, 65 (01) : 49 - 57
  • [36] Characterization of Streptococcus pneumoniae invasive serotype 19A isolates from Argentina (1993-2014)
    Gagetti, Paula
    Faccone, Diego
    Reijtman, Vanesa
    Fossati, Sofia
    Rodriguez, Marisa
    Veliz, Omar
    Ceriana, Paola
    Regueira, Mabel
    Corso, Alejandra
    VACCINE, 2017, 35 (35) : 4548 - 4553
  • [37] In vitro activity of ceftizoxime, ceftazidime, cefuroxime, ceftriaxone, cefotaxime, and penicillin against Streptococcus pneumoniae as determined by three quantitative methods
    Barry, AL
    Brown, SD
    Fuchs, PC
    EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES, 1996, 15 (04) : 344 - 346
  • [38] Response to "Letter to the Editor: Vaccine Failures in Pediatric Cases Caused by Streptococcus pneumoniae Serotype 19A"
    Gonullu, Erdem
    Soysal, Ahmet
    Yildiz, Ismail
    Aydemir, Gokhan
    Tunc, Turan
    Karabocuoglu, Metin
    HUMAN VACCINES & IMMUNOTHERAPEUTICS, 2020, 16 (10) : 2511 - 2512
  • [39] Evidence of a clonal expansion of Streptococcus pneumoniae serotype 19A in adults as in children assessed by the DiversiLabA® system
    Hurmic, O.
    Grall, N.
    Al Nakib, M.
    Poyart, C.
    Grondin, S.
    Ploy, M. -C.
    Varon, E.
    Raymond, J.
    EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES, 2014, 33 (11) : 2067 - 2073
  • [40] Whole genome sequencing of macrolide resistant Streptococcus pneumoniae serotype 19A sequence type 416
    Petra Spanelova
    Vladislav Jakubu
    Lucia Malisova
    Martin Musilek
    Jana Kozakova
    Costas C. Papagiannitsis
    Ibrahim Bitar
    Jaroslav Hrabak
    Annalisa Pantosti
    Maria del Grosso
    Helena Zemlickova
    BMC Microbiology, 20